Abstrakt
Jednán se o komentář k článku Pereira LA, Meng C, Gonc MA, et al. Etelcalcetide controls secondary hyperparathyroidism and raises sclerostin levels in hemodialysis patients previously uncontrolled with cinacalcet.
Nefrologia 2022, https://doi.org/10.1016/j.nefroe.2022.11.014.